PPT-HPTN 082: Evaluation

HPTN 082 Evaluation of daily oral PrEP as a primary prevention strategy for young African women Connie Celum and Sinead Delany Moretlwe HPTN 082HERS cochairs How do you create demand What information is needed. www.dotbu.org. .). LTO Evaluation Process. LTO position must be at . least four (4) months long. .. Principals should meet with the OT prior to the evaluation . to provide an overview of the process and areas of consideration, i.e. classroom management, assessment and evaluation, planning, etc.. Learning objectives. By the end of this presentation, you will be able to:. Explain evaluation design . Describe . the differences between types of evaluation . designs. Identify . the key . elements . Myron S. Cohen, MD. Yeargan-Bate Eminent Professor. Medicine, Microbiology and Epidemiology. Director, Institute for Global Health & Infectious Diseases. Long Acting Parenteral . PrEP. Drug Development . An Update on Injectable . P. revention. Alex R Rinehart, PhD. Director, Global HIV Prevention Strategy. ViiV Healthcare. Cabotegravir LA (CAB LA) for PrEP. CAB is an investigational HIV integrase strand transfer inhibitor and analogue of dolutegravir. for PrEP. Sinead Delany-Moretlwe. University of the Witwatersrand. IAS, Amsterdam, July 2018. Women account for more than half of adults living with HIV globally. Young women are twice as likely to be living with HIV as young men. Laying the Groundwork Before Your First Evaluation Diana Epstein, Ph.D, CNCS Office of Research and Evaluation Adrienne DiTommaso, MPA, CNCS Office of Research and Evaluation Learning objectives Understand five critical activities for your first grant cycle Program Evaluation Webinar Series Part 1: “Top Roadblocks on the Path to Good Evaluation– And How to Avoid Them” Presented by: Tom Chapel Top Roadblocks on the Path to Good Evaluation– And How to Avoid Them PrEP. Antibody Mediated Prevention: . The AMP Studies. 1. Nyaradzo Mgodi, . MBChB. , . MMed. Co-Chair, The AMP Studies. University of Zimbabwe - University of California San Francisco Collaborative Research . Community Engagement in HIV Prevention Efficacy Trials: The AMP Studies’ Experience . (HVTN 704/HPTN 085 & HVTN 703/HPTN 081) . Michele Andrasik, PhD. Director, Social & Behavioral Sciences and Community Engagement. HOPS. History. Observation. Palpation . Special Tests. Evaluation of the ANKLE. History. MAPPS. M = . Mechanism. of injury. A = . Acute. or chronic. P = . Previous. . history. of injury. P = . Pain. Factors. . Evaluation by the . designer. . Every time the designer makes a key design decision or completes a design milestone, then chosen and competing alternatives should be evaluated using the analysis techniques.. Audrey Pettifor PhD. University of North Carolina at Chapel Hill. Social determinants that increase risk. Education/Schooling. Poverty. Gender Inequity/Violence. Mental Health. Alcohol/Drugs. Randomized Controlled Trial. EVALUATION STATUS IN MAURITANIA. By . Mohamed Fadel Ould. Ahmed Yahya. . Deputy. . President. . Nouakchott, 07/28/2011. In accordance with:. Millennium Development Goals (. Part I:Real World Evaluation Approaches . May 16, 2012 . YALE-GRIFFIN PREVENTION RESEARCH CENTER. David L. Katz, MD, MPH. Valentine Yanchou Njike, MD, MPH. Jesse Reynolds, MS. Engage stakeholders . Describe the program .